VIOLA, Anna
 Distribuzione geografica
Continente #
EU - Europa 71
NA - Nord America 14
AS - Asia 13
AF - Africa 7
Totale 105
Nazione #
IT - Italia 40
NO - Norvegia 17
US - Stati Uniti d'America 12
IN - India 9
EG - Egitto 7
FR - Francia 6
IE - Irlanda 3
CA - Canada 2
GB - Regno Unito 2
JP - Giappone 2
DE - Germania 1
FI - Finlandia 1
KR - Corea 1
SG - Singapore 1
UA - Ucraina 1
Totale 105
Città #
Messina 17
Tromsø 15
Chennai 5
Ashburn 4
Caltanissetta 4
Gharbia 4
Al Mansurah 3
Dublin 3
Rome 3
Wexford 3
Catania 2
Edmonton 2
Liverpool 2
Mangalore 2
Paris 2
Redlands 2
Tokyo 2
Altamura 1
Berlin 1
Council Bluffs 1
Gurgaon 1
Isola della Scala 1
Jeonju 1
Kongsberg 1
Lappeenranta 1
Lillehammer 1
Milan 1
Nantes 1
Pachino 1
Sale Marasino 1
Sassari 1
Thane 1
Totale 90
Nome #
Tissue levels of Tumour Necrosis Factor-alpha as molecular biomarker of inflammation and prediction of sustained treatment response in patients with Ulcerative Colitis., file de3e52b5-2fab-762d-e053-3705fe0a30e0 65
Effectiveness and Safety Profiles of Biological Therapies in Inflammatory Bowel Disease: Real Life Data from an Active Pharmacovigilance Project, file f2579077-b867-4dbd-b858-aef06f955d70 13
Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease, file ffd684a6-71aa-446f-8bb1-d63bfc357f33 7
Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?, file b260c48e-0045-4b16-80c6-75dc86aa7211 5
Disease patterns in late-onset ulcerative colitis: Results from the IG-IBD “AGED study”, file de3e52b0-d60a-762d-e053-3705fe0a30e0 3
DWI ratios: New indexes for Crohn's disease activity at magnetic resonance enterography?, file 709871e5-240f-4aef-9b9d-2eea9d2cbe23 2
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab, file de3e52b4-32f8-762d-e053-3705fe0a30e0 2
IL PAZIENTE ANZIANO CON MALATTIA INFIAMMATORIA CRONICA INTESTINALE: OSSERVAZIONI IN UN GRUPPO DI PAZIENTI AMBULATORIALI, file de3e52b5-4100-762d-e053-3705fe0a30e0 2
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches, file 2b4bb0ea-2677-43f4-9245-a800c4e99d30 1
One-year effectiveness and safety of ustekinumab in ulcerative colitis: a multicenter real-world study from Italy, file cdaf95cc-9c4d-4a39-bb21-c15501534151 1
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study, file de3e52b3-94fd-762d-e053-3705fe0a30e0 1
Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn’s disease: Need for a multidisciplinary approach, file de3e52b4-32fb-762d-e053-3705fe0a30e0 1
Comparative Efficacy of Vedolizumab and Adalimumab in Ulcerative Colitis Patients Previously Treated With Infliximab, file de3e52b4-4e16-762d-e053-3705fe0a30e0 1
Predictors of Covid-19 vaccination acceptance in IBD patients: a prospective study, file de3e52b5-703e-762d-e053-3705fe0a30e0 1
Totale 105
Categoria #
all - tutte 243
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 243


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 1 0 0 0
2020/20214 0 0 0 0 0 1 2 0 0 1 0 0
2021/202239 0 0 0 0 0 0 0 4 7 4 18 6
2022/202320 1 0 7 0 0 0 1 0 3 2 3 3
2023/202441 0 0 4 7 10 1 6 8 3 2 0 0
Totale 105